Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Melanoma

  Free Subscription


26.03.2018

1 Am J Ophthalmol
1 BMJ
1 Br J Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Cutis
2 J Am Acad Dermatol
2 Melanoma Res
2 Oncogene
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. DAMATO B, Hope-Stone L, Cooper B, Brown S, et al
    Patient-Reported Outcomes and Quality of Life after Treatment of Choroidal Melanoma: a Comparison of Enucleation vs Radiotherapy in 1596 patients.
    Am J Ophthalmol. 2018 Mar 16. pii: S0002-9394(18)30113.
    PubMed     Text format     Abstract available


    BMJ

  2. MUINONEN-MARTIN AJ, O'Shea SJ, Newton-Bishop J
    Amelanotic melanoma.
    BMJ. 2018;360:k826.
    PubMed     Text format    


    Br J Cancer

  3. SCHOLZ SL, Cosgarea I, Susskind D, Murali R, et al
    NF1 mutations in conjunctival melanoma.
    Br J Cancer. 2018 Mar 21. pii: 10.1038/s41416-018-0046.
    PubMed     Text format     Abstract available


    Cancer Lett

  4. MARSAVELA G, Aya-Bonilla CA, Warkiani ME, Gray ES, et al
    Melanoma circulating tumor cells: Benefits and challenges required for clinical application.
    Cancer Lett. 2018;424:1-8.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. ZHANG G, Wu LW, Mender I, Barzily-Rokni M, et al
    Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
    Clin Cancer Res. 2018 Mar 21. pii: 1078-0432.CCR-17-2773.
    PubMed     Text format     Abstract available


    Cutis

  6. SACO M, Zager J, Messina J
    Metastatic melanoma and prostatic adenocarcinoma in the same sentinel lymph node.
    Cutis. 2018;101:E1-E3.
    PubMed     Text format    


    J Am Acad Dermatol

  7. GARNIER M, Zaragoza J, Beneton N, Bens G, et al
    High neutrophil-to-lymphocyte ratio before starting anti-PD1 immunotherapy predicts poor outcome in patients with metastatic melanoma.
    J Am Acad Dermatol. 2018 Mar 12. pii: S0190-9622(18)30366.
    PubMed     Text format    

  8. SVOBODA RM, Gharia MJ, Shell J, Gregory WD, et al
    Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of non-melanoma skin cancer: Management implications.
    J Am Acad Dermatol. 2018 Mar 12. pii: S0190-9622(18)30369.
    PubMed     Text format    


    Melanoma Res

  9. CHESNEY J, Imbert-Fernandez Y, Telang S, Baum M, et al
    Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors.
    Melanoma Res. 2018 Mar 21. doi: 10.1097/CMR.0000000000000444.
    PubMed     Text format     Abstract available

  10. NASARRE P, Bonilla IV, Metcalf JS, Hilliard EG, et al
    TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma.
    Melanoma Res. 2018 Mar 16. doi: 10.1097/CMR.0000000000000440.
    PubMed     Text format     Abstract available


    Oncogene

  11. ZUO Q, Liu J, Huang L, Qin Y, et al
    AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0205.
    PubMed     Text format     Abstract available

  12. MISKOLCZI Z, Smith MP, Rowling EJ, Ferguson J, et al
    Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0209.
    PubMed     Text format     Abstract available


    Oncol Rep

  13. SI L, Yan X, Hao W, Ma X, et al
    Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
    Oncol Rep. 2018;39:2160-2170.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: